1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Deadline was April 8, 2026, which has now passed (today is April 17, 2026). The page is still accessible and matches the grant.
Community Outreach Service Grant is a grant from CalDerm (California Society of Dermatology and Dermatologic Surgery) that funds medical students and dermatology residents in developing and implementing community-based skin health projects. Each award provides $3,000 to support projects advancing public education, skin health awareness, and access to dermatologic care in California communities.
Eligible topics include sun safety, skin cancer prevention, access to care in underserved communities, cultural competency in dermatologic care, and skin health education for specific populations. Applicants must be enrolled in accredited California programs, have a faculty mentor, and identify a community partner. The 2026 application deadline was April 8, 2026.
Get alerted about grants like this
Save a search for “CalDerm” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
California Society of Dermatology and Dermatologic Surgery - Service Grant Community Outreach Committee Practice Management Committee 2026 NorCal Resident/Fellow Abstracts 2026 NorCal Networking Events Industry Partners Directory Firefighter Skin Cancer Screening Program Community Outreach Committee Practice Management Committee 2026 NorCal Resident/Fellow Abstracts 2026 NorCal Networking Events Industry Partners Directory Firefighter Skin Cancer Screening Program calderm Community Outreach Service Grant for Medical Students and Dermatology Residents Purpose: To support medical students and residents in developing and implementing innovative community-based projects that further CalDerm’s mission of promoting skin health through public education, awareness, and advocacy.
Topic Focus Areas: Projects should relate to dermatology and community health, with topics including but not limited to sun safety, skin health, and healthcare access.
Skin cancer prevention and education Access to dermatologic care in underserved communities Cultural competency in dermatologic care Skin health education for specific populations (e.g., pediatrics, elderly, occupational groups, minority populations) Current medical students or dermatology residents in accredited programs in California.
Applicants must have a faculty mentor to supervise and oversee project implementation, including compliance with institutional research requirements and use of funds. Applicants must also identify a community partner.
Community collaboration is required and may include: Government agencies (e.g., Departments of Public Health, school districts) Primary and secondary schools Nonprofit organizations with 501(c)(3) or 170(c) tax-exempt IRS status Faith-based organizations Community-based health or social service agencies Civic and volunteer associations Applications Open: February 17, 2026 Application Deadline: April 8th, 2026 Award Notification: April 17-19, 2026 - Grant Recipient Announced at the 2026 NorCal Conference Project Presentation: Project presented at the 2027 Fall Symposium Award Amount: $3000 per project Educational materials and outreach supplies Event-related costs (e.g., venue, permits, speakers) Modest travel or transportation tied to project delivery Printing, marketing, or communication directly related to the project Capital expenses, such as construction or large equipment purchases Salaries or stipends for the grantee or staff not directly delivering project content Debt repayment or reduction Indirect costs not clearly tied to the project (e.g., general admin, utilities) Lobbying or political activity Projects based primarily outside of California Gifts or prizes not directly tied to educational goals Alcohol, cannabis, or controlled substances Fundraising or development efforts Cover Page (Applicants and faculty mentor information, project title, community affiliations) Project Proposal (3–5 pages) including: Background and significance Target population and community partner(s) Project plan, timeline, and methods Evaluation metrics (how outcomes will be measured and impact assessed) Institutional research requirements (if applicable) Sustainability or long-term goals (if applicable) Faculty Mentor Letter of Support Letter of Commitment from Community Partner Review and Selection Criteria Proposals will be evaluated by the CalDerm Community Outreach Committee based on: Relevance to dermatologic community health Innovation and feasibility of the proposed project Strength and appropriateness of community partnerships Sustainability and potential for ongoing impact Clarity of objectives, methods, and evaluation plan Appropriateness of budget Reporting and Deliverables Within 30 days of project completion, the Grantee agrees to submit: A brief written report (1–2 pages) summarizing project activities, outcomes, and lessons learned A 1–2 slide PowerPoint presentation highlighting the project’s impact At least two high-quality photos documenting the project Scanned receipts or records accounting for at least 75% of the total grant amount.
Any funds not used or not supported with appropriate documentation must be returned to CalDerm within 30 days of the reporting deadline.
Deliver a poster presentation and submission for an oral presentation at the next CalDerm Conference (NorCal Conference or Fall Symposium) after project completion Acknowledge CalDerm as the funding source in all deliverables and materials Administration and Oversight Grant Oversight: CalDerm Community Outreach Committee Institutional, Administrative & Fiscal Oversight: Faculty mentor to guarantee compliance with institutional research requirements, and manage and approve expenses in compliance with CalDerm funding guidelines.
For questions or clarifications, contact CalDerm at staff@calderm. org California Society of Dermatology and Dermatologic Surgery 201 E Center St Ste 112 PMB 3148 Anaheim, California 92805 Powered by Wild Apricot Membership Software
Based on current listing details, eligibility includes: Current medical students or dermatology residents in accredited programs in California. Applicants must have a faculty mentor and identify a community partner. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $3,000 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is April 8, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.